Trade Mark Journal No.2018/016 20 April 2018
UK00003291099 19 February 2018 (5,40,42,44)
TORQUE
International priority date claimed: 28 August 2017
(United States)
(87585927)
International priority date claimed: 28 August 2017
(United States)
(87585866)
International priority date claimed: 28 August 2017
(United States)
(87585877)
International priority date claimed: 28 August 2017
(United States)
(87585883)
- Class 5
- Pharmaceuticals and medical preparations for immunotherapy, cell therapy, immune cell therapy, and T-cell therapy; pharmaceuticals and medical preparations for use in the prevention and treatment of cancer, tumors, and diseases and disorders of the immune system; pharmaceuticals and medical preparations of biotherapeutics, immunotherapeutics, immunomodulators, immunostimulants, immunogenics, antibodies, cell therapeutics, cells, immune cells, and T-cells.
- Class 40
- Manufacturing services for others in the fields of pharmaceuticals and medicine, namely manufacturing of biotherapeutics, immunotherapeutics, immunomodulators, immunostimulants, immunogenics, antibodies, cell therapeutics, cells, immune cells, and T-cells.
- Class 42
- Pharmaceutical research and development; scientific and medical research in the fields of immunology, oncology, biology, biochemistry, and chemistry.
- Class 44
- Medical services; therapeutic services in the fields of immunotherapy, cell therapy, immune cell therapy, and T-cell therapy.
Torque Therapeutics, Inc.
Representative: Brabners LLP